公开(公告)号：US20170136146A1

公开(公告)日：2017-05-18

申请号：US15127399

申请日：2015-03-10

Applicant: AMOREPACIFIC CORPORATION

Inventor： Hyun Jung SHIN ,  Jin Kyu CHOI ,  Byung Gyu KIM ,  Dae Bang SEO

IPC: A61L27/24 ,  A61L27/50 ,  A61L27/20

CPC classification number: A61L27/24 ,  A61L27/20 ,  A61L27/505 ,  A61L27/52 ,  A61L2400/06 ,  C08L5/08

Abstract: The present invention relates to a parenteral composition for maintaining the efficacy of a filler for a long time, containing a collagen hydrolysate as an active ingredient. The composition, according to the present invention, can maintain the efficacy of a hyaluronic acid filler for a longer time, thereby enabling the effect thereof to be maintained irrespective of a smaller frequency of filler operations, and thus there is an advantage of also reducing skin irritation. In addition, there is an advantage of enabling an immediate effect since an administration method is simple as a parenteral administration and enables direct penetration into the skin.

公开(公告)号：US20160263079A1

公开(公告)日：2016-09-15

申请号：US15160239

申请日：2016-05-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu KIM ,  Hyun Woo JEONG ,  Su Kyung KIM ,  Si Young CHO ,  Chan Woong PARK ,  Dae Bang SEO ,  Wan Gi KIM ,  Sang Jun LEE

IPC: A61K31/34 ,  A23L2/52 ,  A61K36/258

CPC classification number: A61K31/34 ,  A23L2/52 ,  A23L33/105 ,  A23L33/11 ,  A23V2002/00 ,  A61K36/258

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

公开(公告)号：US20160263078A1

公开(公告)日：2016-09-15

申请号：US15160218

申请日：2016-05-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Byung Gyu KIM ,  Hyun Woo JEONG ,  Su Kyung KIM ,  Si Young CHO ,  Chan Woong PARK ,  Dae Bang SEO ,  Wan Gi KIM ,  Sang Jun LEE

IPC: A61K31/34 ,  A61K36/258

CPC classification number: A61K31/34 ,  A23L2/52 ,  A23L33/105 ,  A23L33/11 ,  A23V2002/00 ,  A61K36/258

Abstract: The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

公开(公告)号：US20130171277A1

公开(公告)日：2013-07-04

申请号：US13722676

申请日：2012-12-20

Applicant: AMOREPACIFIC CORPORATION

Inventor： Su Kyung KIM ,  Hyun Jung SHIN ,  Chan Su RHA ,  Seung Hun KIM ,  Bum Jin LEE ,  Young Kyung KIM ,  Dae Bang SEO ,  Wan Gi KIM ,  Jin Oh CHUNG ,  Sang Jun LEE

IPC: A61K36/82

CPC classification number: A61K36/82

Abstract: Disclosed is a composition for preventing or improving metabolic syndrome, including a tea plant leaf extract, a tea plant flower extract and a tea plant seed extract as active ingredients.

Abstract translation: 本发明提供一种用于预防或改善代谢综合征的组合物，包括茶植物叶提取物，茶植物花提取物和茶植物种子提取物作为活性成分。